Vanda Pharmaceuticals (VNDA)

$18.00 0.15 (0.83%)

16:00 EDT VNDA Stock Quote Delayed 30 Minutes

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor Apr 26, 2021

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

4 Top Efficient Stocks to Buy for Stellar Returns

13 Biotechnology Stocks to Buy Now

7 Biotechnology Stocks to Buy Now

More Articles

Volume:

Previous Close -

Market Cap 1.00B

PE Ratio 31.03

EPS 0.58

Volume (Avg. Vol.) 244,756

Day's Range -

52-Week Range 10.07 - 21.86

Dividend & Yield N/A (N/A)

VNDA Stock Predictions, Articles, and Vanda Pharmaceuticals News

From InvestorPlace
From the Web

5 Stocks With Superb Earnings Revisions — SNOW AKER RPT BBRY VNDA

By Portfolio Grader Oct 21, 2016

This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Prime Earnings Revisions — SNOW VNDA AKER RPT ACH

By Portfolio Grader Oct 7, 2016

This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

Biggest Movers in Manufacturing Stocks Now – SPU MESO KTOV CCUR

By Portfolio Grader Oct 6, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

5 Stocks With Prime Earnings Revisions — SNOW VNDA GRPN AKER ACH

By Portfolio Grader Sep 30, 2016

This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Great Earnings Revisions — SNOW VNDA AKER GRPN ACH

By Portfolio Grader Sep 23, 2016

This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Prime Earnings Revisions — VNDA ACH RICE NSA AEM

By Portfolio Grader Sep 16, 2016

This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Strong Earnings Revisions — VNDA PBR.A GPOR ACH NSA

By Portfolio Grader Sep 9, 2016

This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

6 Biotechnology Stocks to Buy Now

By Portfolio Grader Sep 5, 2016

The grades of 6 Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Hottest Manufacturing Stocks Now – VNDA PDEX DMPI YECO

By Portfolio Grader Aug 25, 2016

The following stocks were moving the Manufacturing sector today.

18 Biotechnology Stocks to Sell Now

By Portfolio Grader Jun 13, 2016

This week, 18 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biggest Movers in Manufacturing Stocks Now – PSDV CCXI CFRX STML

By Portfolio Grader May 30, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – RLYP VNDA VRX IXYS

By Portfolio Grader May 27, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

3 Great ETFs for a Biotech Rebound – BBP CNCR XBI

By Todd Shriber, InvestorPlace Contributor May 2, 2016

Biotech stocks and ETFs have recently been rebounding in impressive fashion. Tactical investors might want to take a look at BBP, XBI and CNCR.

6 Biotechnology Stocks to Buy Now

By Portfolio Grader Dec 31, 2014

Six biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Why Avis, Chesapeake Energy, and Vanda Pharmaceuticals are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor Dec 23, 2014

A revision higher in the Commerce Department's Q3 GDP sends Wall Street traders home happy again, while Avis, Chesapeake Energy, and Vanda Pharmaceuticals all prosper.

5 Buy-Rated Small-Cap Biotech Stocks to Add to Your Watchlist

From StockNews.com Sep 3, 2021

Biotech companies’ increasing focus on integrating advanced technology into their research projects to develop viable drugs for treating various critical diseases, and growing demand from an aging population, should drive the biotech industry’s growth. In addition to the industry’s solid growth prospects, we think a low-interest-rate environment should benefit small-cap biotech companies Vanda (VNDA), Anika (ANIK), Tarsus (TARS), BioDelivery Sciences (BDSI), and Champions Oncology (CSBR). So, let’s pore over these names.

Novavax Appoints New CFO Amid Inordinate Delay In COVID-19 Vaccine Authorization

From Benzinga Aug 16, 2021

Novavax, Inc. (NASDAQ: NVAX) announced new hires to its executive team even as it is stymied by the delay in getting authorization for its COVID-19 vaccine in the U.S. What...

3 No-Brainer Biotech Stocks to Invest $2,000 in Right Now

From StockNews.com Aug 16, 2021

The biotech industry is playing a crucial role in fighting against COVID-19 and is also making considerable progress in finding cures for several other diseases with the help of advanced technologies. With continuing innovation and strong financials, we think biotech concerns Takeda Pharmaceutical (TAK), Exelixis (EXEL), and Vanda Pharmaceuticals (VNDA) are well-positioned to continue benefiting from the industry’s solid growth prospects. So read on for details.

Technical Short Put Spread Fade the Dip Trade and Trigger in Vanda Pharmaceuticals Inc

From Capital Market Laboratories Jun 12, 2021

The Techncial Trigger Driven Option Trade Right Before Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Earnings.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

From Benzinga Aug 3, 2021

Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3...

Vanda Pharmaceuticals Inc (VNDA) Q2 2021 Earnings Call Transcript

From The Motley Fool Jul 29, 2021

VNDA earnings call for the period ending June 30, 2021.